BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30666403)

  • 1. Characterization of blood-brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis.
    Bell L; Koeniger T; Tacke S; Kuerten S
    Histochem Cell Biol; 2019 Jun; 151(6):489-499. PubMed ID: 30666403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of LTi and T
    Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S
    J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
    Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
    Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
    Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
    Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice.
    Polepole P; Bartenslager A; Liu Y; Petro TM; Fernando S; Zhang L
    J Med Virol; 2021 Jun; 93(6):3813-3823. PubMed ID: 32543727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-26, preferentially produced by T
    Broux B; Zandee S; Gowing E; Charabati M; Lécuyer MA; Tastet O; Hachehouche L; Bourbonnière L; Ouimet JP; Lemaitre F; Larouche S; Cayrol R; Bouthillier A; Moumdjian R; Lahav B; Poirier J; Duquette P; Arbour N; Peelen E; Prat A
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32788322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a CD19 PET tracer for detecting B cells in a mouse model of multiple sclerosis.
    Stevens MY; Cropper HC; Lucot KL; Chaney AM; Lechtenberg KJ; Jackson IM; Buckwalter MS; James ML
    J Neuroinflammation; 2020 Sep; 17(1):275. PubMed ID: 32948198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
    Kuerten S; Angelov DN
    Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
    Front Immunol; 2022; 13():861486. PubMed ID: 35664003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.